科亚治疗公司(NASDAQ:COYA)报告季度每股亏损$(0.98)，比分析师共识预期的$(1.09)高出10.09%。与去年同期每股亏损$(0.79)相比，这一数字下降了24.05%。公司报告季度销售额为$3.554百万，低于分析师共识预期的$3.601百万，差距为1.30%。与去年同期销售额$6.002百万相比，这一数据下降了40.79%。

以上内容来自Benzinga Earnings专栏，原文如下：

Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.98) per share which beat the analyst consensus estimate of $(1.09) by 10.09 percent. This is a 24.05 percent decrease over losses of $(0.79) per share from the same period last year. The company reported quarterly sales of $3.554 million which missed the analyst consensus estimate of $3.601 million by 1.30 percent. This is a 40.79 percent decrease over sales of $6.002 million the same period last year.